These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5707445)

  • 21. [Use of a preparation with a base of L-citrulline and L-acetylaspartic acid in minors with "mental fatigue" and slight "mental retardation"].
    Gaffuri G
    G Psichiatr Neuropatol; 1966; 94(3):701-13. PubMed ID: 4381170
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heart insufficiency and potassium-magnesium-aspartic acid].
    Becker F
    Landarzt; 1966 Jan; 42(2):77-8. PubMed ID: 5940673
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of some diseases of the myocardium with potassium aspartate].
    Capritti AG
    Minerva Med; 1967 Apr; 58(33):1512-5. PubMed ID: 6026634
    [No Abstract]   [Full Text] [Related]  

  • 24. [Potassium-magnesium-aspartate in the therapy of heart diseases].
    Lordick H
    Med Welt; 1968 Aug; 33():1790-7. PubMed ID: 5732182
    [No Abstract]   [Full Text] [Related]  

  • 25. [The exhaustion syndrome and its treatment with desmethylimipramine (Pertofran)].
    Ambrozi L; Birkmayer W
    Wien Med Wochenschr; 1966 Sep; 116(39):791-2. PubMed ID: 5997680
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lithium aspartate in drug dependence].
    Daunderer M
    Fortschr Med; 1982 Sep; 100(33):1500-2. PubMed ID: 7129311
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effect of aspartic acid in hepatic diseases].
    FODOR O; ABEL C; MANASIA M; SANTAY I
    Rev Int Hepatol; 1959; 9(2):211-8. PubMed ID: 13658756
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ornithine and aspartic acid: catalizers of ureogenesis. Recent use in hepato-protective therapy].
    CEDRANGOLO F
    Riforma Med; 1962 Dec; 76():1453-6. PubMed ID: 14019581
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy of physical and mental manifestations of fatigue in geriatrics].
    Cocchi C; Provvedini D; Daccò L
    Clin Ter; 1980 Apr; 93(1):89-97. PubMed ID: 6108819
    [No Abstract]   [Full Text] [Related]  

  • 30. [The combination of acetylaspartic acid and citrulline studied in the sanatorium environment].
    Malossini A; Corato P
    G Ital Mal Torace; 1966; 20(1):33-8. PubMed ID: 5934394
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of hepatic comas by ornithine alpha-ketoglutarate].
    Tête R; Paliard P; Vachon A
    Rev Lyon Med; 1966 Apr; 15(8):371-8. PubMed ID: 5942225
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolism of ammonia and its disorders; therapeutic importance of aspartic acid salts (outline of an experimental and clinical study)].
    LABORIT H; WEBER B; JOUANY J; NIAUSSAT P; BARON C
    Presse Med (1893); 1958 Dec; 66(93):2125-8. PubMed ID: 13633785
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aspartic acid salts, substances with anti-fatigue properties].
    GHIELMETTI G; BOCCHIA A
    Boll Chim Farm; 1959 Mar; 98(3):139-43. PubMed ID: 13651403
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of the clinical effect of Ca-1-d1-aspartate (Calciretard), of Ca-2-aminoethanol phosphate (Ca-EAP) and of the cortisones.
    Nieper HA
    Agressologie; 1968; 9(3):471-5. PubMed ID: 5722614
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of magnesium L-aspartate on the platelet function of thrombocytasthenia.
    Hyodo S; Shirakawa M; Aso T
    Isr J Med Sci; 1965 Jul; 1(4):860-1. PubMed ID: 5856134
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
    Jiang XR; Chen WP; Shi HL; Zhou LF
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of alfa-D,L-methylaspartate on ornithine cycle reactions and urea excretion in rats.
    CEDRANGOLO F; DELLA PIETRA G; DE LORENZO F; PAPA S; CITTADINI D
    Enzymologia; 1963 Mar; 25():308-14. PubMed ID: 14019580
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment with association of aminoacids of dysmnesic disturbances in chronic alcoholics: some clinical and psychometric findings].
    Madeddu A; Sacchi C
    Clin Ter; 1965 Jul; 34(2):131-48. PubMed ID: 5839471
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.
    Krishnan R; Cella D; Leonardi C; Papp K; Gottlieb AB; Dunn M; Chiou CF; Patel V; Jahreis A
    Br J Dermatol; 2007 Dec; 157(6):1275-7. PubMed ID: 17916204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.